AuntMinnieEurope

Think more deeply about the structural, procedural, or operational bottlenecks stacking on top of one another, Dr. Rizwan Malik told UKIO delegates.

The great AI debate: expensive failure or vital prerequisite?

The spotlight fell brightly on AI at Tuesday's plenary session at the U.K. Imaging and Oncology Congress. The global expert panel scrutinized the current status of AI and the challenges ahead.

Featured

Flat-detector CT showing catheter position following contralateral middle meningeal artery embolization in a case where ipsilateral access was not possible.

MMA embolization for chronic subdural hematoma: Routine takes shape

Experts gathered at the European Conference on Interventional Oncology ECIO 2026 in Basel to discuss the latest advances in minimally invasive cancer care.

ECIO 2026: interventional oncology's next step

Breast Cancer Social

What's the optimum approach for B3 breast lesions?

June 9, 2026

Screening mammograms and AI score changes are depicted over time in two individuals with screen-detected cancer. Full-field digital mammograms show craniocaudal (top) and mediolateral (bottom) views of the left and right breast. The description below each mammogram indicates whether AI scores from three AI-based computer-aided detection systems (AI-1, AI-2, and AI-3) were above or below the 90th percentile. (A) Mammograms from three screening time points (in 2009, 2011, and 2014) in an individual who was diagnosed in February 2014 (at age 73 years) with a left-sided 25-mm grade 2 invasive breast carcinoma, no special type (arrow). Mammographic breast density was classified as BI-RADS B on all three mammograms. (B) Mammograms from four screening time points (in 2009, 2011, 2013, and 2015) in an individual who was diagnosed in October 2015 (at age 65 years) with a left-sided 45-mm grade 2 lobular carcinoma (arrow). Mammographic breast density was classified as BI-RADS C on all four mammograms. Screen-detected cancers were defined as those diagnosed within 90 days for individuals who were recalled at screening (*).

AI may provide early breast cancer alerts from mammograms

June 9, 2026

AI for CT & PET/CT Imaging

AI for CT & PET/CT Imaging

June 4, 2026

Biparametric prostate MRI identified clinically significant Gleason 3+4 prostate cancer using T2-weighted imaging, diffusion-weighted imaging, and ADC mapping alone.

SERAM 2026: Biparametric MRI cuts time and costs in prostate cancer imaging

June 8, 2026

Check out our Cases of the Week!

60-year-old man with lesion on carcinoma follow-up

A 60-year-old man presented for follow-up imaging at an outpatient imaging center. He had recently been diagnosed with tongue squamous cell carcinoma.

34-year-old man with anomaly on cardiac CT

39-year-old man with orbital proptosis, possible orbital mass

Experts gathered at the European Conference on Interventional Oncology ECIO 2026 in Basel to discuss the latest advances in minimally invasive cancer care.

ECIO 2026: interventional oncology's next step

What's the optimum approach for B3 breast lesions?

AI may provide early breast cancer alerts from mammograms

Tattoo pigments can have significant impact on imaging

SERAM 2026: Biparametric MRI cuts time and costs in prostate cancer imaging

Think more deeply about the structural, procedural, or operational bottlenecks stacking on top of one another, Dr. Rizwan Malik told UKIO delegates.

The great AI debate: expensive failure or vital prerequisite?

AI can mislead radiologists -- and make the error more persuasive

SERAM 2026: AI-assisted triage in deep neck infections

AI diagnostic aid helps novice MRI readers, but experts not so much

RöKo 2026: Nikolaou on AI policy, data gaps, and a prostate cancer paradox

Lung Tumors

KA Imaging awarded $150K to develop AI triage tool

1.92M patients waiting for NHS diagnostic tests in England

SCCT, SCAI publish fractional flow reserve in CCTA guideline

Royal Philips, WellSpan Health announce seven-year imaging alliance

QT Imaging secures clearance for CT scanner in Saudi Arabia

KA Imaging awarded $150K to develop AI triage tool

By AuntMinnie.com staff writers

The tool would flag suspected findings, including pulmonary nodules, consolidation, pleural fluid, and pneumothorax.

June 9, 2026

1.92M patients waiting for NHS diagnostic tests in England

By AuntMinnieEurope.com staff writers

The waiting list has grown by 500,000 since 2022, according to health technology firm Magentus.

June 8, 2026

Waiting Room Seniors Masks 400

SCCT, SCAI publish fractional flow reserve in CCTA guideline

By AuntMinnie.com staff writers

The document was crafted by a team from King's College London in the U.K.

June 8, 2026

SERAM 2026: AI chest triage cuts referrals without raising CT use

By Claudia Tschabuschnig

A real-world implementation study from a Spanish regional hospital suggests that AI-assisted chest radiograph triage may reduce specialist referrals without driving additional CT imaging.

June 4, 2026

An AI system highlights multiple abnormalities on a chest radiograph, including a pulmonary nodule (nódulo pulmonar), pleural effusion (derrame pleural), and alveolar syndrome/consolidation (síndrome alveolar).

AI detects lung cancer nodules well but shows low specificity

By Kate Madden Yee

The finding suggests the models offer “a potential role as adjunctive tools for ruling out malignancy” rather than classifying it.

June 4, 2026

Am 2020 06 26 16 29 2945 Cancer Lung 400

Royal Philips, WellSpan Health announce seven-year imaging alliance

By AuntMinnie.com staff writers

Royal Philips and WellSpan Health have entered a strategic alliance to bring new imaging products to WellSpan's health system.

June 4, 2026

WellSpan New York Hospital

Image-guided focal laser ablation effective for prostate cancer

By Amerigo Allegretto

MRI-directed, ultrasound-guided TPLA may be a promising technique to treat prostate cancer while avoiding radical therapies.

June 3, 2026

Preablation, postablation, and recurrence multiparametric MRI scans depict a 63-year-old man treated with transperineal focal laser ablation (TPLA) for localized prostate cancer. Clinical parameters included an initial prostate-specific antigen (PSA) level of 7.2 ng/mL, a Prostate Imaging Reporting and Data System (PI-RADS) grade 4 lesion (red circles) in the right apical peripheral zone, and a maximum tumor length of 5 mm. MRI-guided targeted biopsy confirmed a Gleason score 3+4 prostate cancer tumor. (A) Pre-ablation axial T2-weighted MRI scan and apparent diffusion coefficient (ADC) image shows the apical PI-RADS 4 lesion (circles). (B) Six-month post-ablation axial T2-weighted MRI scan and ADC image show cystic necrosis (arrows). There was no evidence of recurrence; the PSA level was 1.5 ng/mL. (C) One-year after ablation, the patient’s PSA level had increased to 4.3 ng/mL. Axial T2-weighted MRI scan and the ADC image shows a recurrent lesion (blue circles) in the right apical peripheral zone adjacent to the ablation scar. Targeted biopsy confirmed Gleason score 3+4 prostate cancer, which was classified as in-field recurrence of clinically significant prostate cancer and subsequently re-treated with TPLA. In summary, serial multiplanar MRI demonstrates treatment response after TPLA with post-ablation necrosis, followed by MRI-detected IFR confirmed with biopsy at 12-month follow-up. Multiparametric MRI was performed with a 3.0-T MRI scanner (Skyra; Siemens Healthineers) using T2-weighted, diffusion-weighted, and ADC sequences, with gadobenate dimeglumine contrast material administration (Bracco Diagnostics).

QT Imaging secures clearance for CT scanner in Saudi Arabia

By AuntMinnie.com staff writers

The company has now secured regulatory clearance in both Saudi Arabia and the United Arab Emirates.

June 3, 2026

Spain's radiology society warns CT renewal still far short despite new procurement drive

By Claudia Tschabuschnig

SERAM's new equipment guide says Spain needs around 80 CT scanners a year. A new government purchasing framework covers 62 over two years, and the MRI and vascular equivalents are still missing.

June 3, 2026

Gioele Gatto/Pexels

AI can mislead radiologists -- and make the error more persuasive

By Claudia Tschabuschnig

A study from Milan puts hard numbers on how often radiologists follow a wrong AI recommendation and whether explainable AI can help.

June 2, 2026

Grad-CAM heatmaps showing the AI model's areas of attention overlaid on standard mammography views, as displayed to radiologists during the XAI-assisted reading sessions.

Curium to invest €32M in French radiopharmaceutical facility

By AuntMinnieEurope.com staff writers

The investment will go toward development of a new production line for lutetium-177 PSMA-I&T, a targeted radioligand therapy.

June 1, 2026

France Flag Button 400

4DMedical acquires contextflow to expand into European lung imaging

By AuntMinnie.com staff writers

4DMedical is entering the European market with its acquisition of contextflow.

June 1, 2026

Lung Technology Medicine 400